Annual report for 2021
April 2022
Section I important tips, contents and definitions
The board of directors, the board of supervisors and the directors, supervisors and senior managers of the company guarantee that the contents of the annual report are true, accurate and complete without false records, misleading statements or major omissions, and bear individual and joint legal liabilities.
Gao Yang, the person in charge of the company, Gao Yang, the person in charge of accounting, and Bai Lu, the person in charge of the accounting organization (Accounting Supervisor), declare that they guarantee the authenticity, accuracy and completeness of the financial report in this annual report.
All directors have attended the meeting of the board of directors to consider this report.
The forward-looking statements such as future plans involved in this report do not constitute the company's substantive commitment to investors. Investors and relevant persons should maintain sufficient risk awareness and understand the differences between plans, forecasts and commitments.
The company describes the risks that the company may face in its future operation in "Xi. Prospect of the company's future development" in Section III "management discussion and analysis" of this report. Please pay attention to it.
The company plans not to distribute cash dividends, bonus shares or increase share capital with provident fund.
catalogue
Section I important tips, contents and definitions Wrong! No bookmarks defined. Section II Company Profile and main financial indicators Wrong! No bookmarks defined. Section III Management Discussion and Analysis Wrong! No bookmarks defined. Section IV corporate governance Wrong! No bookmarks defined. Section V environmental and social responsibility Wrong! No bookmarks defined. Section VI important matters Wrong! No bookmarks defined. Section VII changes in shares and shareholders Wrong! No bookmarks defined. Section 8 preferred shares Wrong! No bookmarks defined. Section IX relevant information of bonds Wrong! No bookmarks defined. Section x financial report Wrong! No bookmarks defined.
Directory of documents for future reference
1、 Financial statements containing the signatures and seals of the person in charge of the company, the person in charge of accounting and the person in charge of accounting institutions. 2、 The original of the audit report with the seal of the accounting firm and the signature and seal of the certified public accountant. 3、 Originals of all company documents and announcements publicly disclosed by the company during the reporting period. 4、 The company's 2021 annual report signed by the chairman of the company. 5、 The place where the above documents for future reference are prepared: the Securities Department of the company and Shenzhen Stock Exchange.
interpretation
Explanatory item refers to the explanatory content
The company / company / listed company / Berry Genomics Co.Ltd(000710) refers to Berry Genomics Co.Ltd(000710)
CSRC / CSRC refers to the China Securities Regulatory Commission
Shenzhen stock exchange refers to Shenzhen Stock Exchange
Company Law refers to the company law of the people's Republic of China
Securities Law refers to the securities law of the people's Republic of China
Articles of Association
Yuan / 10000 yuan refers to RMB yuan / 10000 yuan
The same period of last year / last period refers to the period from January 1, 2020 to December 31, 2020
This reporting period / reporting period / current period refers to the period from January 1, 2021 to December 31, 2021
Beijing Beirui / beiruihekang refers to Beijing beiruihekang Biotechnology Co., Ltd
Hangzhou Beirui refers to Hangzhou beiruihekang Gene Diagnosis Technology Co., Ltd
Beijing Laboratory refers to Beijing beiruihekang medical laboratory Co., Ltd
Chongqing Beirui refers to Chongqing Beirui medical laboratory Co., Ltd
Chengdu laboratory refers to Chengdu beiruihekang medical laboratory Co., Ltd
Qingdao laboratory refers to Qingdao beiruihekang medical laboratory Co., Ltd
Fujian Herui / Herui gene refers to Fujian Herui Gene Technology Co., Ltd
Yuanyuan gene refers to Beijing Yuanyuan Gene Technology Co., Ltd
Fuzhou Ruisheng refers to Fuzhou Ruisheng Investment Management Co., Ltd
Fujian Beirui / Fujian Berry Genomics Co.Ltd(000710) refers to Fujian beiruihekang Gene Technology Co., Ltd
Fujian health management refers to Fujian beiruihekang Health Management Co., Ltd
Hong Kong berry genomics Co., Ltd
Yasneng / xcelom refers to yasneng Gene Technology Co., Ltd. xcelom limited
Shanmi holding refers to shanmi Holding Co., Ltd
Illumina means Illumina, Inc
NIPT refers to non-invasive prenatal testing technology
PGs refers to preimplantation Ge netic screening
EGFR refers to epidermal growth factor receptor gene mutation detection
Precar project refers to prospective surveillance for very early hepat OCE llular arcinoma
Wellmind biotechnology Holdings Limited
Xi'an Haorui refers to Xi'an Haorui Gene Technology Co., Ltd
Act means act genomics Holdings Company Limited
Section II Company Profile and main financial indicators
1、 Company information
Stock abbreviation Berry Genomics Co.Ltd(000710) Stock Code: Berry Genomics Co.Ltd(000710)
Listed on Shenzhen Stock Exchange
Chinese name of the company Berry Genomics Co.Ltd(000710)
Chinese abbreviation of the company Berry Genomics Co.Ltd(000710)
Foreign name of the company (if any) berry genomics Co., Ltd
Abbreviation of the company's foreign name (if any) berry genomics
The legal representative of the company is Gao Yang
Registered address: No. 333, Chengdu Auto City Avenue, Chengdu Economic and Technological Development Zone (Longquanyi District), Sichuan Province
Postal code of registered address 610100
The registered address of the company was changed from Chengdu high tech Industrial Development Zone to Lailong village, Shiling sub district office, Longquanyi District, Chengdu. Later, the historical change of the registered address of the company was changed from Lailong village, Shiling sub district office, Longquanyi District, Chengdu to No. 333, Chengdu Auto City Avenue, Chengdu Economic and Technological Development Zone (Longquanyi District), Sichuan Province
Office address: Building 5, courtyard 4, shengshengyuan Road, Science Park, Changping District, Beijing
Postal code of office address 102206
Company website: https://www.berrygenomics.com com.
E-mail Berry Genomics Co.Ltd(000710) @berrygenomics.com.
2、 Contact person and contact information
Secretary of the board of directors and securities affairs representative
Name: AI Wenlu Dong Yuhuan
Contact address: Building 5, courtyard 4, shengshengyuan Road, Science Park, Changping District, Beijing Building 5, courtyard 4, shengshengyuan Road, Science Park, Changping District, Beijing
Tel: 0105325918801053259188
Fax 0108430682401084306824
E-mail Berry Genomics Co.Ltd(000710) @berrygenomics.com. Berry Genomics Co.Ltd(000710) @berrygenomics.com.
3、 Information disclosure and preparation location
Website of the stock exchange where the company discloses its annual report http://www.cn.info.com.cn.
The media name and website of the annual report disclosed by the company include China Securities News, Shanghai Securities News, securities times and Securities Daily
The company's annual report is prepared at the Securities Investment Department of the company
4、 Registration changes
Organization Code: 91510112633134930l
On August 10, 2017, the company disclosed the changes in its main business since the listing of the company issuing shares to buy assets and selling major assets and related party transactions (such as the implementation and listing report of new shares), and the implementation of the company's major asset restructuring was completed.
The company's main business is to change from the design, production, processing and sales of automobile and motorcycle parts to the sales of gene testing services, equipment and reagents based on high-throughput sequencing.
On August 10, 2017, the company disclosed the implementation of the changes of previous controlling shareholders (if any) in the issuance of shares to purchase assets and the sale of major assets and related party transactions and the report on the listing of new shares, and the implementation of the company's major asset restructuring was completed. The controlling shareholder of the company was changed from Chengdu Tianxing instrument (Group) Co., Ltd. to Mr. Gao Yang.
5、 Other relevant information: accounting firm employed by the company
Name of accounting firm: Shanghui accounting firm (special general partnership)
Office address of the accounting firm: 25 / F, No. 755, Weihai Road, Shanghai
Name of signature accountant: Zhang Wei, Ding Feiyun
Recommendation agencies hired by the company to perform continuous supervision duties during the reporting period □ applicable √ not applicable to financial consultants hired by the company to perform continuous supervision duties during the reporting period □ applicable √ not applicable VI. major accounting data and financial indicators whether the company needs to retroactively adjust or restate the accounting data of previous years □ yes √ no
20212020 year-on-year increase or decrease 2019
Operating income (yuan)
